Orser Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-4,030
| Closed | -$234K | – | 45 |
|
2023
Q3 | $234K | Hold |
4,030
| – | – | 0.23% | 50 |
|
2023
Q2 | $258K | Hold |
4,030
| – | – | 0.26% | 50 |
|
2023
Q1 | $279K | Hold |
4,030
| – | – | 0.31% | 47 |
|
2022
Q4 | $290K | Hold |
4,030
| – | – | 0.42% | 40 |
|
2022
Q3 | $286K | Hold |
4,030
| – | – | 0.51% | 33 |
|
2022
Q2 | $310K | Hold |
4,030
| – | – | 0.4% | 42 |
|
2022
Q1 | $294K | Hold |
4,030
| – | – | 0.18% | 72 |
|
2021
Q4 | $251K | Sell |
4,030
-1,000
| -20% | -$62.3K | 0.13% | 86 |
|
2021
Q3 | $298K | Hold |
5,030
| – | – | 0.16% | 76 |
|
2021
Q2 | $336K | Buy |
5,030
+200
| +4% | +$13.4K | 0.17% | 77 |
|
2021
Q1 | $305K | Hold |
4,830
| – | – | 0.2% | 75 |
|
2020
Q4 | $300K | Hold |
4,830
| – | – | 0.19% | 76 |
|
2020
Q3 | $291K | Hold |
4,830
| – | – | 0.23% | 64 |
|
2020
Q2 | $284K | Sell |
4,830
-180
| -4% | -$10.6K | 0.26% | 53 |
|
2020
Q1 | $279K | Hold |
5,010
| – | – | 0.39% | 46 |
|
2019
Q4 | $319K | Buy |
+5,010
| New | +$319K | 0.31% | 63 |
|
2019
Q3 | – | Sell |
-2,800
| Closed | -$227K | – | 69 |
|
2019
Q2 | $227K | Sell |
2,800
-2,210
| -44% | -$179K | 0.23% | 63 |
|
2019
Q1 | $239K | Sell |
5,010
-32,720
| -87% | -$1.56M | 0.26% | 62 |
|
2018
Q4 | $2.11M | Hold |
37,730
| – | – | 2.43% | 11 |
|
2018
Q3 | $2.11M | Sell |
37,730
-1,070
| -3% | -$59.9K | 2.02% | 13 |
|
2018
Q2 | $2.2M | Sell |
38,800
-2,210
| -5% | -$125K | 1.91% | 11 |
|
2018
Q1 | $2.11M | Buy |
+41,010
| New | +$2.11M | 1.95% | 11 |
|